Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 131.265
2.39 %
$ 14 B
Market Cap
-182.31
P/E
ITCI - TOTAL OTHER INCOME
Total Other Income ITCI - Intra-Cellular Therapies, Inc.
20.3 M
LAST VALUE
260.20%
2 YEAR CAGR
23.29%
5 YEAR CAGR
43.44%
10 YEAR CAGR